Recent studies have demonstrated that p-STAT3 overexpression is associated with poorer prognosis in patients with gastric cancer [18], colorectal carcinoma [19], pancreatic cancer [20], and lung cancer [21]. The gene discussed is STAT3; the disease is lung carcinoma.